Skip to main content

Erythropoiesis Stimulating Agents: 4 Medicare contractor policies compared

4 Local Coverage Determinations in the current Medicare Coverage Database export carry the title "Erythropoiesis Stimulating Agents", between them covering 50 states and territories. 4 of them have a billing and coding article with a diagnosis list, ranging from 326 to 1,291 covered ICD-10-CM codes. 2 record a source policy it was derived from. The table below is the fastest way to see which version governs a given state and how far the versions have drifted.

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: Medicare Coverage Database LCD export: MCD release November 12, 2026 (effective November 8, 2026); Medicare Coverage Database billing and coding articles: MCD release November 12, 2026 (effective November 8, 2026). Next CMS release: weekly, every Thursday.

Policies with this title
4
States covered
50
Versions with a coded article
4
Revision dates
2025-05-29 to 2026-10-04

Every version by contractor

Open a version for its full policy text, contracts, codes and related NCDs. Covered codes are the count of ICD-10-CM codes in the version's billing and coding article; a dash means the export attaches no coded article.

Local Coverage Determinations titled "Erythropoiesis Stimulating Agents"
LCDContractorStatesRevisedCovered codesPolicy words
L34356CGS Administrators, LLCKY OH2026-10-041,2531,810
L34633Wisconsin Physicians Service Insurance CorporationAK AL AR AZ CA CO CT DE FL GA HI IA ID IL IN KS KY LA MA MD ME MI MO MS MT NC ND NE NH NJ NM NV OH OK OR PA RI SC SD TN TX UT VA VT WA WI WV WY2025-05-293261,703
L39237Palmetto GBAAL GA NC SC TN VA WV2026-09-171,0811,819
L40334Wellpoint FederalCT IL MA ME MN NH NY RI VT WI2026-07-151,2911,955

Lineage

The Medicare Coverage Database records the source policy a determination was derived from: L34356 from L31867; L34633 from L31074. A shared source explains why the opening paragraphs read alike; the revision dates and the diagnosis counts above show where the versions have since parted.

Which diagnoses each contractor covers

Across the 4 versions with a coded billing and coding article, 1,489 ICD-10-CM codes are covered by at least one contractor: 20 by every version and 1,469 (99%) by only some of them. L34356 (CGS Administrators, LLC) covers the most codes no other version lists (104). L34633 (Wisconsin Physicians Service Insurance Corporation) leaves out the most codes that every other version covers (912), the version where a diagnosis accepted elsewhere is most often absent. The comparison is mechanical: it counts codes on the lists and does not weigh the policy text, frequency limits or documentation rules, which can matter as much as the list.

Unique codes appear on that version's covered list only; missing codes are covered by every other version but not by this one. Lists are the union of the coded billing and coding articles linked to each LCD (MCD release 2026-11-12).

Covered ICD-10-CM codes per version of Erythropoiesis Stimulating Agents
LCDContractorArticlesCoveredOnly hereMissing
L34356CGS Administrators, LLCA564621,2531045
L34633Wisconsin Physicians Service Insurance CorporationA5679532686912
L39237Palmetto GBAA589821,0813210
L40334Wellpoint FederalA603811,29110

Where the lists part

Three-character ICD-10-CM categories ranked by how many of their codes are covered by some versions and not others; a category near the top is where checking the local list matters most.

ICD-10-CM categories with the most codes only some versions of Erythropoiesis Stimulating Agents cover
CategoryCategory title (FY2027)Codes that differ
M05Rheumatoid arthritis with rheumatoid factor123
C44Other and unspecified malignant neoplasm of skin84
C82Follicular lymphoma81
C84Mature T/NK-cell lymphomas73
M06Other rheumatoid arthritis68
C83Non-follicular lymphoma64
C81Hodgkin lymphoma63
K51Ulcerative colitis42
C50Malignant neoplasm of breast36
C85Other specified and unspecified types of non-Hodgkin lymphoma36
C91Lymphoid leukemia27
K50Crohn's disease [regional enteritis]24

Code-by-contractor sample

100 of the 1,469 codes covered by some versions and not others, codes that most versions cover first and no more than three per category in the first pass. Y means the version's covered list includes the code.

100 of the 1,469 ICD-10-CM codes that only some versions of Erythropoiesis Stimulating Agents cover
ICD-10-CMDescription (FY2027)L34356L34633L39237L40334
B17.10Acute hepatitis C without hepatic comaYY—Y
B17.11Acute hepatitis C with hepatic comaYY—Y
B18.2Chronic viral hepatitis CYY—Y
B19.20Unspecified viral hepatitis C without hepatic comaYY—Y
B19.21Unspecified viral hepatitis C with hepatic comaYY—Y
C00.0Malignant neoplasm of external upper lipY—YY
C00.1Malignant neoplasm of external lower lipY—YY
C00.2Malignant neoplasm of external lip, unspecifiedY—YY
C01Malignant neoplasm of base of tongueY—YY
C02.0Malignant neoplasm of dorsal surface of tongueY—YY
C02.1Malignant neoplasm of border of tongueY—YY
C02.2Malignant neoplasm of ventral surface of tongueY—YY
C03.0Malignant neoplasm of upper gumY—YY
C03.1Malignant neoplasm of lower gumY—YY
C04.0Malignant neoplasm of anterior floor of mouthY—YY
C04.1Malignant neoplasm of lateral floor of mouthY—YY
C04.8Malignant neoplasm of overlapping sites of floor of mouthY—YY
C05.0Malignant neoplasm of hard palateY—YY
C05.1Malignant neoplasm of soft palateY—YY
C05.2Malignant neoplasm of uvulaY—YY
C06.0Malignant neoplasm of cheek mucosaY—YY
C06.1Malignant neoplasm of vestibule of mouthY—YY
C06.2Malignant neoplasm of retromolar areaY—YY
C07Malignant neoplasm of parotid glandY—YY
C08.0Malignant neoplasm of submandibular glandY—YY
C08.1Malignant neoplasm of sublingual glandY—YY
C09.0Malignant neoplasm of tonsillar fossaY—YY
C09.1Malignant neoplasm of tonsillar pillar (anterior) (posterior)Y—YY
C09.8Malignant neoplasm of overlapping sites of tonsilY—YY
C10.0Malignant neoplasm of valleculaY—YY
C10.1Malignant neoplasm of anterior surface of epiglottisY—YY
C10.2Malignant neoplasm of lateral wall of oropharynxY—YY
C11.0Malignant neoplasm of superior wall of nasopharynxY—YY
C11.1Malignant neoplasm of posterior wall of nasopharynxY—YY
C11.2Malignant neoplasm of lateral wall of nasopharynxY—YY
C12Malignant neoplasm of pyriform sinusY—YY
C13.0Malignant neoplasm of postcricoid regionY—YY
C13.1Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspectY—YY
C13.2Malignant neoplasm of posterior wall of hypopharynxY—YY
C44.1321Sebaceous cell carcinoma of skin of right upper eyelid, including canthus——YY
C44.1322Sebaceous cell carcinoma of skin of right lower eyelid, including canthus——YY
C44.1391Sebaceous cell carcinoma of skin of left upper eyelid, including canthus——YY
C49.A1Gastrointestinal stromal tumor of esophagus——YY
C49.A2Gastrointestinal stromal tumor of stomach——YY
C49.A3Gastrointestinal stromal tumor of small intestine——YY
C4A.0Merkel cell carcinoma of lip——YY
C4A.111Merkel cell carcinoma of right upper eyelid, including canthus——YY
C4A.112Merkel cell carcinoma of right lower eyelid, including canthus——YY
C56.3Malignant neoplasm of bilateral ovaries——YY
C57.8Malignant neoplasm of overlapping sites of female genital organs——YY
C7A.010Malignant carcinoid tumor of the duodenum——YY
C7A.011Malignant carcinoid tumor of the jejunum——YY
C7A.012Malignant carcinoid tumor of the ileum——YY
C7B.01Secondary carcinoid tumors of distant lymph nodes——YY
C7B.02Secondary carcinoid tumors of liver——YY
C7B.03Secondary carcinoid tumors of bone——YY
C80.2Malignant neoplasm associated with transplanted organ——YY
C88.00Waldenstrom macroglobulinemia not having achieved remission——YY
C88.90Malignant immunoproliferative disease, unspecified not having achieved remission——YY
C94.40Acute panmyelosis with myelofibrosis not having achieved remissionYY——
C94.41Acute panmyelosis with myelofibrosis, in remissionYY——
C94.42Acute panmyelosis with myelofibrosis, in relapseYY——
D00.01Carcinoma in situ of labial mucosa and vermilion border——YY
D00.02Carcinoma in situ of buccal mucosa——YY
D00.03Carcinoma in situ of gingiva and edentulous alveolar ridge——YY
D01.0Carcinoma in situ of colon——YY
D01.1Carcinoma in situ of rectosigmoid junction——YY
D01.2Carcinoma in situ of rectum——YY
D02.0Carcinoma in situ of larynx——YY
D02.1Carcinoma in situ of trachea——YY
D02.21Carcinoma in situ of right bronchus and lung——YY
D04.0Carcinoma in situ of skin of lip——YY
D04.111Carcinoma in situ of skin of right upper eyelid, including canthus——YY
D04.112Carcinoma in situ of skin of right lower eyelid, including canthus——YY
D05.01Lobular carcinoma in situ of right breast——YY
D05.02Lobular carcinoma in situ of left breast——YY
D05.11Intraductal carcinoma in situ of right breast——YY
D06.0Carcinoma in situ of endocervix——YY
D06.1Carcinoma in situ of exocervix——YY
D06.7Carcinoma in situ of other parts of cervix——YY
D07.0Carcinoma in situ of endometrium——YY
D07.4Carcinoma in situ of penis——YY
D07.5Carcinoma in situ of prostate——YY
D09.0Carcinoma in situ of bladder——YY
D09.19Carcinoma in situ of other urinary organs——YY
D09.21Carcinoma in situ of right eye——YY
D37.039Neoplasm of uncertain behavior of the major salivary glands, unspecified——YY
D41.20Neoplasm of uncertain behavior of unspecified ureter——YY
D43.2Neoplasm of uncertain behavior of brain, unspecified——YY
D47.3Essential (hemorrhagic) thrombocythemia——YY
M16.0Bilateral primary osteoarthritis of hip——YY
M16.11Unilateral primary osteoarthritis, right hip——YY
M16.12Unilateral primary osteoarthritis, left hip——YY
M17.0Bilateral primary osteoarthritis of knee——YY
M17.11Unilateral primary osteoarthritis, right knee——YY
M17.12Unilateral primary osteoarthritis, left knee——YY
N18.30Chronic kidney disease, stage 3 unspecifiedYY——
Q85.03Schwannomatosis——YY
T37.5X5AAdverse effect of antiviral drugs, initial encounterY——Y
T37.5X5SAdverse effect of antiviral drugs, sequelaY——Y

Download every covered code with a column per LCD (CSV). The LCD coverage variation report ranks every multi-contractor title by how far its lists diverge.

How to use the comparison

Start from the state where the service is furnished and open that contractor's version; its billing and coding article carries the diagnosis codes the claims system will test. For a group that bills in several jurisdictions, the version with the smallest covered list is the safe common denominator for pre-service review, and the version with the largest list shows what documentation can support an appeal elsewhere. The L39237 version is the one most searched for this title; the LCD lookup guide explains how jurisdictions are assigned, and the LCD hub lists every topic that more than one contractor has written.

For teams evaluating QuickIntell software

Where QuickIntell fits across jurisdictions

For teams working across MAC jurisdictions, evaluate how requirements, source policies and documentation review should be organized for each case. Confirm jurisdiction-specific scope and supported actions during a QuickAuth evaluation; compare claim and denial follow-up separately in QuickRCM.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions

Why are there 4 LCDs called "Erythropoiesis Stimulating Agents"?

Each Medicare Administrative Contractor writes its own Local Coverage Determination for its jurisdiction. 4 contractors publish a policy with this title covering 50 states; they often start from one contractor's text and then revise separately, so dates, criteria and diagnosis lists differ by jurisdiction.

Which "Erythropoiesis Stimulating Agents" LCD applies to my claim?

The one written by the contractor that processes the claim: the A/B MAC for the state where the service is furnished, or the DME MAC region for equipment. The table lists each policy's states; open the policy for that jurisdiction and its billing and coding article.

How different are the diagnosis lists?

Across the 4 versions with a coded billing and coding article, 1,489 ICD-10-CM codes are covered by at least one contractor: 20 by every version and 1,469 (99%) by only some of them. A diagnosis accepted under one contractor's version can deny under another's, so a group that bills in several jurisdictions checks the list of the contractor that processes each claim.

When were these policies last revised?

Revision effective dates run from 2025-05-29 to 2026-10-04. A claim is judged against the version in force on the date of service.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

Policy metadata and code counts are reproduced from the CMS Medicare Coverage Database export as an operational reference. Verify against the current LCD and article on cms.gov before billing. Not legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.